Litcius/Paper detail

Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) – splicing factor axis

Sarah Mole, Arwa A. Faizo, Hegel R. Hernandez-Lopez, Megan E. Griffiths, Andrew Stevenson, Sally Roberts, Sheila V. Graham

2020Journal of General Virology39 citationsDOIOpen Access PDF

Abstract

The infectious life cycle of human papillomaviruses (HPVs) is tightly linked to keratinocyte differentiation. Evidence suggests a sophisticated interplay between host gene regulation and virus replication. Alternative splicing is an essential process for host and viral gene expression, and is generally upregulated by serine arginine-rich splicing factors (SRSFs). SRSF activity can be positively or negatively controlled by cycles of phosphorylation/dephosphorylation. Here we show that HPV16 infection leads to accumulation of the paradigm SRSF protein, SRSF1, in the cytoplasm in a keratinocyte differentiation-specific manner. Moreover, HPV16 infection leads to increased levels of cytoplasmic and nuclear phosphorylated SRSF1. SR protein kinase 1 (SRPK1) phosphorylates SRSF1. Similar to HPV upregulation of SRSF1, we demonstrate HPV upregulation of SRPK1 via the viral E2 protein. SRPK1 depletion or drug inhibition of SRPK1 kinase activity resulted in reduced levels of SRSF1, suggesting that phosphorylation stabilizes the protein in differentiated HPV-infected keratinocytes. Together, these data indicate HPV infection stimulates the SRPK1-SRSF axis in keratinocytes.

Topics & Concepts

BiologyVirologyHost factorSR proteinSplicing factorSerineRNA splicingHost (biology)ArginineAlternative splicingCell biologyVirusAmino acidGeneticsPhosphorylationMessenger RNAGeneRNAinterferon and immune responsesRNA Research and SplicingVirus-based gene therapy research
Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) – splicing factor axis | Litcius